定义严重喘的临床缓解:海湾地区的专家意见使用修改后的Delphi方法
Adeeb A Bulkhi1, A Elkkari2, Bader J Alghamdi3
1Internal Medicine Department, Umm Al-Qura University, P.O. 21955, Makkah, Saudi Arabia.
Respiratory medicine
|May 5, 2025
概括
定义严重喘的临床缓解对于新的生物治疗非常重要. 专家们同意了包括没有症状,恶化,稳定的肺功能和12个月不服用口服类固醇在内的标准.
科学领域:
- 肺病学和免疫学 肺病学和免疫学
- 喘研究 喘研究
- 临床试验设计 临床试验设计
背景情况:
- 生物学和以患者为中心正在改变喘管理.
- 经过修订的临床目标要求明确定义喘缓解.
- 了解喘表型,内型和病理生理学是必不可少的.
研究的目的:
- 建立严重喘临床缓解的综合标准.
- 在当前喘治疗的背景下,就定义缓解收集专家的共识.
- 提供严重喘临床缓解的操作定义.
主要方法:
- 系统地收集和分析海湾国家的肺病学和免疫学专家的专家见解.
- 使用了研讨会前的调查,科学研讨会,以及两轮的德尔菲调查.
- 关于"治疗后"缓解的标准的专家意见.
主要成果:
- 在严重喘中定义临床缓解的商定的综合标准.
- 缓解的关键标准包括持续缺乏喘症状和恶化.
- 稳定的肺功能和至少12个月不使用全身皮质类固醇也是决定性因素.
结论:
- 该研究提供了一种基于共识的定义,用于严重喘的临床缓解.
- 这些标准对于指导治疗目标和评估生物学时代的结果至关重要.
- 建立的标准为未来的喘管理策略提供了一个框架.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-III: Symptoms and Complications
2.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.4K
Asthma-IV: Nursing Management
2.9K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
2.9K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
161
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
161
COPD: Management Using Bronchodilators and Corticosteroids
125
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
125
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


